研究者
J-GLOBAL ID:201801000435218308   更新日: 2020年01月06日

藤田 二郎

Jiro Fujita
所属機関・部署:
論文 (10件):
  • Kusakabe S, Fukushima K, Maeda T, Motooka D, Nakamura S, Fujita J, Yokota T, Shibayama H, Oritani K, Kanakura Y. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation. British journal of haematology. 2019
  • Ueda T, Maeda T, Kusakabe S, Fujita J, Fukushima K, Yokota T, Shibayama H, Tomiyama Y, Kanakura Y. Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation. International journal of hematology. 2019. 109. 2. 197-205
  • Nozaki K, Ezoe S, Hamaguchi M, Tsutsumi K, Kusakabe S, Morikawa Y, Fujita J, Fukushima K, Maeda T, Shibayama H, Kumanogo A, Kanakura Y. Unexpected Complication of R-CHOP Chemotherapy: Rapidly Progressive Bronchiolitis Obliterans Syndrome. European journal of case reports in internal medicine. 2019. 6. 11. 001266
  • Sakuragi M, Hayashi S, Maruyama M, Kiyokawa T, Nagamine K, Fujita J, Maeda T, Kato H, Kashiwagi H, Kanakura Y, Tomiyama Y. Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation. International journal of hematology. 2018. 107. 3. 320-326
  • Nishiura N, Ujimoto D, Fujita J, Maeda T, Nakagawa Y, Kashiwagi H, Oritani K, Tomiyama Y, Kanakura Y. Autoimmune bullous disease and Hashimoto's disease complicated by acquired hemophilia A. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2017. 58. 3. 233-238
もっと見る
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る